Clinical trial
The Effect of Dexmedetomidine on the Incidence of Acute Kidney Injury in EVAR
NCT04766047 is registered in ClinicalTrials.gov with University of Thessaly as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Dexmedetomidine on the Incidence of Acute Kidney Injury in EVAR
- Lead sponsor
- University of Thessaly
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 30, 2021
- Completion date
- February 1, 2024
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, dexmedetomidine, endovascular aortic repair